Monoclonal antibody (MAb) treatments have been safe and effective in averting severe Covid-19 infections when given early, but supplies have been scarce. Intermountain Healthcare used its supply to ...

A systems-level approach to transforming health care centers structural racism as a root cause of disparities, offering a collective ...

Three proposals for improving the law to reflect 21st-century drug development practices.

I’m the Chief Physician Executive and the President of the Physician Services division at Hackensack Meridian Health, which is a multihospital integrated delivery system in New Jersey. We go all the ...

To report employment trends and wages in health care in a systematic way, the authors use data from the Current Employment Statistics program that is administered by the U.S. Bureau of Labor ...

Achieving health equity is increasingly understood to be an essential priority for providers and for organizations throughout the larger health care system. The authors describe a four-tier model that ...

Emergency care providers have been the “availablists” for both life-threatening conditions and immediate care generally. The Covid-19 pandemic has transformed our mindset and approach to emergency ...

The impact of using AI to guide patient care or operational processes depends on the interplay between the AI model’s output, the decision-making protocol based on that output, the capacity of the ...

Early in the Covid-19 pandemic, health care workers expressed desperate needs for personal protective equipment (PPE), face masks, and medical accessories. In response, three-dimensional (3D) printing ...

Given the United States’ high spending on emergency department (ED) visits and the crowding that many EDs experience, there is great interest in shifting care for low-severity conditions to ...

While there is no off-the-shelf playbook for the current coronavirus pandemic, existing management research points to ways that organizations can navigate tumultuous and uncharted times through ...

Are we paying too much for new drugs before we know how well they work? This innovative pricing model proposes postponing major rewards until efficacy is established — which could help both patients ...